吸烟与前列腺癌死亡风险:美国退伍军人研究
该回顾性队列研究纳入2000至2015年美国退伍军人医疗系统诊断的73668例前列腺癌患者,分析当前吸烟、既往吸烟与从不吸烟者的前列腺癌特异性死亡率差异。中位随访5.9年,当前吸烟与前列腺癌特异性死亡风险升高相关(sHR 1.14,95%CI 1.05-1.24,P=0.002),而既往吸烟无显著关联。
要点
- 当前吸烟与前列腺癌特异性死亡风险升高14%相关(sHR 1.14)。
- 既往吸烟者前列腺癌特异性死亡风险与从不吸烟者无显著差异。
- 诊断前列腺癌是讨论戒烟的重要时机。
核心结论
- 诊断时当前吸烟与更高的前列腺癌死亡风险及其他原因死亡风险相关,而既往吸烟与前列腺癌特异性死亡无关,提示吸烟可能是可改变的风险因素。
研究设计与样本
- 回顾性队列研究,纳入2000至2015年美国退伍军人医疗系统诊断的前列腺癌患者73668例,采用竞争风险回归分析前列腺癌特异性死亡率。
主要发现
- 队列中当前吸烟者22608例(30.7%),既往吸烟者23695例(32.1%),从不吸烟者27365例(37.1%),中位随访5.9年。
- 当前吸烟者诊断时更年轻(中位年龄63 vs 从不吸烟66,p<0.001),IV期疾病比例更高(5.3% vs 4.3%,p<0.04)。
- 当前、既往、从不吸烟者的10年前列腺癌特异性死亡率分别为5.2%、4.8%、4.5%。
- 竞争风险回归显示当前吸烟与前列腺癌特异性死亡风险升高相关(sHR 1.14,95%CI 1.05-1.24,p=0.002),既往吸烟无显著关联。
- 分层回归提示当前吸烟增加的死亡风险部分归因于肿瘤特征。
临床怎么用
- 在前列腺癌诊断时,应将戒烟咨询作为临床管理的一部分,鼓励当前吸烟者戒烟以可能降低死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cigarette smoking is a risk factor for mortality in several genitourinary cancers, likely due to accumulation of carcinogens in urine. However, in prostate cancer (PC) the link has been less studied. We evaluated differences in prostate cancer-specific mortality (PCSM) between current smokers, past smokers, and never smokers diagnosed with PC. METHODS: This was a retrospective cohort study of PCSM in men diagnosed with PC between 2000 and 2015 treated in the US Veterans Affairs health care system, using competing risk regression analyses. RESULTS: The cohort included 73,668 men (current smokers: 22,608 (30.7%), past smokers: 23,695 (32.1%), and never smokers: 27,365 (37.1%)). Median follow-up was 5.9 years. Current smoker patients were younger at presentation (median age current: 63, never: 66; p < 0.001), and had more advanced disease stage (stage IV disease current: 5.3%, never: 4.3%; p < 0.04). The 10-year incidence of PCSM was 5.2%, 4.8%, and 4.5% for current, past, and never smokers, respectively. On competing risk regression, current smoking was associated with increased PCSM (subdistribution hazard ratio: 1.14, 95% confidence interval: (1.05-1.24), p = 0.002), whereas past smoking was not. Hierarchical regression suggests that this increased risk was partially attributable to tumor characteristics. CONCLUSIONS: Smoking at the time of diagnosis is associated with a higher risk of dying from PC as well as other causes of death. In contrast, past smoking was not associated with PCSM suggesting that smoking may be a modifiable risk factor. PC diagnosis may be an important opportunity to discuss smoking cessation.
引用
- Riviere P, Kumar A, Luterstein E, et al. Tobacco smoking and death from prostate cancer in US veterans. Prostate Cancer Prostatic Dis. 2019. PMID: 31624316. doi:10.1038/s41391-019-0178-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。